Amprion announced it raised $11 Million in an initial filing from an offering of $11 Million
07/15/22, 9:08 PM
Location
Money raised
$11 million
Industry
biotechnology
Company Info
Location
149 new montgomery street, 4th floor
san francisco, california, united states
Additional Info
Amprion is a global leader advancing precision medicine for neurodegenerative disorders through seed amplification testing.
Amprion’s SAAmplify™-ɑSYN (formerly SYNTap®) Biomarker Test is a first-in-class, qualitative Laboratory Developed Test (LDT) and the only seed amplification assay available to aid the diagnosis of synucleinopathies such as Parkinson’s disease (PD), Lewy body dementia (LBD/DLB), and Alzheimer’s disease (AD) with Lewy body variant.